Catalyst Funds Management’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,600
Closed -$48.7K 960
2024
Q3
$48.7K Buy
+5,600
New +$48.7K 0.01% 806